Background Inhaled corticosteroids (ICS) are suggested for potential chemoprevention of
lung cancer. Several observational studies in patients with chronic obstructive pulmonary …

Inhaled corticosteroids (ICSs) are often prescribed in patients with chronic obstructive
pulmonary disease (COPD). Their impact on the risk of lung cancer, a leading cause of …

Background It remains uncertain whether there is a protective effect of inhaled
corticosteroids (ICs) against lung cancer in chronic obstructive pulmonary disease (COPD) …

Inhaled corticosteroids (ICS) are commonly prescribed to COPD patients, particularly those
with more advanced stages of the disease. These patients are also at increased risk of lung …

Introduction Current studies investigating the association between inhaled corticosteroid
(ICS) use and risk of lung cancer have yielded inconsistent findings. The aim of this …

Rationale and Objectives: Lung cancer is a frequent cause of death among patients with
chronic obstructive pulmonary disease (COPD). We examined whether the use of inhaled …

RATIONALE AND OBJECTIVES: COPD is associated with an increased risk of lung cancer.
We examined whether inhaled corticosteroids (ICS) used concomitantly with long-acting …

Whether the use of inhaled corticosteroids (ICS) protects patients with chronic obstructive
pulmonary disease (COPD) from lung cancer remains undetermined. In this retrospective …

Inhaled corticosteroids (ICS) might reduce the risk of lung cancer by controlling airway
inflammation in patients with chronic obstructive pulmonary disease (COPD) because both …

Background Inhaled corticosteroids (ICS) have been associated with decreased lung cancer
risk. However, they have been associated with pulmonary infections (tuberculosis [TB] and …